There may be scope for an agreement on drug exports to the US though in the other key area in dispute - regulation of digital services - room for compromise could be limited
The article discusses a potential deal between the US and Ireland (and potentially the EU) to avoid Trump's proposed tariffs on Irish pharmaceutical imports. The deal could involve big pharma declaring more profit and paying more tax in the US, squeezing prices for US consumers, committing to increased US production, and repatriating IP. This would avoid tariffs, while fitting into EU-US trade negotiations.